美国流感嗜血杆菌呼吸道分离株中β-内酰胺酶产生率的下降
Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States.
作者信息
Heilmann Kris P, Rice Cassie L, Miller Ashley L, Miller Norma J, Beekmann Susan E, Pfaller Michael A, Richter Sandra S, Doern Gary V
机构信息
Division of Medical Microbiology, Department of Pathology, Roy J. and Lucille A. Carver University of Iowa College of Medicine, Iowa City, IA 52242, USA.
出版信息
Antimicrob Agents Chemother. 2005 Jun;49(6):2561-4. doi: 10.1128/AAC.49.6.2561-2564.2005.
Abstract
A total of 986 isolates of Haemophilus influenzae from patients with respiratory tract infections in 45 United States medical centers were characterized during the winter of 2002-2003. beta-Lactamase production was noted with 26.2% of isolates; 14.6% were resistant to trimethoprim-sulfamethoxazole. Resistance to other relevant antimicrobial agents was extremely uncommon. In comparison to the results of four previous national surveys conducted since 1994, the prevalence of beta-lactamase production with this pathogen appears to be decreasing.
摘要
2002年至2003年冬季，对美国45个医疗中心呼吸道感染患者的986株流感嗜血杆菌进行了特征分析。26.2%的分离株产生β-内酰胺酶；14.6%对甲氧苄啶-磺胺甲恶唑耐药。对其他相关抗菌药物的耐药情况极为罕见。与1994年以来进行的四项全国性调查结果相比，该病原体产生β-内酰胺酶的患病率似乎在下降。
相似文献
1
Decreasing prevalence of beta-lactamase production among respiratory tract isolates of Haemophilus influenzae in the United States.美国流感嗜血杆菌呼吸道分离株中β-内酰胺酶产生率的下降
Antimicrob Agents Chemother. 2005 Jun;49(6):2561-4. doi: 10.1128/AAC.49.6.2561-2564.2005.
2
3
Mechanisms, molecular and sero-epidemiology of antimicrobial resistance in bacterial respiratory pathogens isolated from Japanese children.从日本儿童分离出的细菌性呼吸道病原体中抗菌药物耐药性的机制、分子及血清流行病学
Ann Clin Microbiol Antimicrob. 2007 Aug 13;6:7. doi: 10.1186/1476-0711-6-7.
4
Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan.从日本患者上呼吸道分离出的β-内酰胺酶阴性氨苄西林耐药流感嗜血杆菌菌株的遗传特征与克隆传播
Antimicrob Agents Chemother. 2007 Nov;51(11):3969-76. doi: 10.1128/AAC.00422-07. Epub 2007 Aug 13.
5
Antimicrobial susceptibility of Haemophilus influenzae isolates collected from 4 centers in Brazil (1990-2003).
Diagn Microbiol Infect Dis. 2006 Jan;54(1):57-62. doi: 10.1016/j.diagmicrobio.2005.08.001. Epub 2005 Nov 14.
6
Serotypes, antimicrobial susceptibility, and beta-lactam resistance mechanisms of clinical Haemophilus influenzae isolates from Bulgaria in a pre-vaccination period.保加利亚疫苗接种前时期临床流感嗜血杆菌分离株的血清型、抗菌药物敏感性及β-内酰胺耐药机制
Scand J Infect Dis. 2013 Feb;45(2):81-7. doi: 10.3109/00365548.2012.710854. Epub 2012 Sep 19.
7
Antibiotic resistance and molecular epidemiology of the beta-lactamase-producing Haemophilus influenzae isolated in Chongqing, China.中国重庆产β-内酰胺酶流感嗜血杆菌的耐药性及分子流行病学研究。
APMIS. 2012 Nov;120(11):926-34. doi: 10.1111/j.1600-0463.2012.02921.x. Epub 2012 May 29.
8
[In vitro sensitivity to antimicrobial agents of Haemophilus influenzae strains isolated from clinical specimens].[从临床标本中分离出的流感嗜血杆菌菌株对抗菌药物的体外敏感性]
Mikrobiyol Bul. 2003 Jan;37(1):19-25.
9
Nasopharyngeal carriage and antimicrobial susceptibility of Haemophilus influenzae among children younger than 5 years of age in Beijing, China.中国北京5岁以下儿童流感嗜血杆菌的鼻咽部携带情况及抗菌药物敏感性
BMC Microbiol. 2015 Feb 4;15:6. doi: 10.1186/s12866-015-0350-7.
10
Characterization of nontypeable Haemophilus influenzae collected from respiratory infections and invasive disease cases in Manitoba, Canada.对从加拿大曼尼托巴省呼吸道感染和侵袭性疾病病例中分离出的非分型流感嗜血杆菌的特征分析。
FEMS Immunol Med Microbiol. 2010 Mar;58(2):277-84. doi: 10.1111/j.1574-695X.2009.00634.x. Epub 2009 Nov 17.
引用本文的文献
1
Antimicrobial resistance and vaccines in Enterobacteriaceae including extraintestinal pathogenic Escherichia coli and Klebsiella pneumoniae.肠杆菌科细菌中的抗菌药物耐药性与疫苗，包括肠外致病性大肠杆菌和肺炎克雷伯菌。
NPJ Antimicrob Resist. 2025 Apr 28;3(1):34. doi: 10.1038/s44259-025-00100-8.
2
Treatment of Haemophilus influenzae Serotype A (Hia) Meningitis in a Pediatric Patient: A Case Report.一名儿科患者的 A 型流感嗜血杆菌（Hia）脑膜炎治疗：病例报告
Cureus. 2025 Mar 8;17(3):e80253. doi: 10.7759/cureus.80253. eCollection 2025 Mar.
3
Convergent impact of vaccination and antibiotic pressures on pneumococcal populations.疫苗接种和抗生素压力对肺炎球菌群体的趋同影响。
Cell Chem Biol. 2024 Feb 15;31(2):195-206. doi: 10.1016/j.chembiol.2023.11.003. Epub 2023 Dec 4.
4
Global and regional burden of attributable and associated bacterial antimicrobial resistance avertable by vaccination: modelling study.全球和区域归因于细菌抗菌药物耐药性和相关抗菌药物耐药性可通过疫苗接种预防的负担：建模研究。
BMJ Glob Health. 2023 Jul;8(7). doi: 10.1136/bmjgh-2022-011341.
5
Assessment of the inclusion of vaccination as an intervention to reduce antimicrobial resistance in AMR national action plans: a global review.评估将疫苗接种纳入减少抗微生物药物耐药性国家行动计划中的干预措施：全球综述。
Global Health. 2022 Oct 17;18(1):85. doi: 10.1186/s12992-022-00878-6.
6
Fatal Meningitis and Sepsis Caused by Nontypeable .不可分型菌引起的致命性脑膜炎和败血症
J Med Cases. 2022 Aug;13(8):396-401. doi: 10.14740/jmc3974. Epub 2022 Aug 19.
7
Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016.2016 年美国侵袭性流感嗜血杆菌的抗菌药物敏感性调查。
Microbiol Spectr. 2022 Jun 29;10(3):e0257921. doi: 10.1128/spectrum.02579-21. Epub 2022 May 10.
8
The impact of human vaccines on bacterial antimicrobial resistance. A review.人类疫苗对细菌抗生素耐药性的影响。综述
Environ Chem Lett. 2021;19(6):4031-4062. doi: 10.1007/s10311-021-01274-z. Epub 2021 Sep 29.
9
Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries.提高抗菌药物使用的策略，特别关注发展中国家
Life (Basel). 2021 Jun 7;11(6):528. doi: 10.3390/life11060528.
10
Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens.利用CRISPR/Cas9、纳米技术及其他策略应对ESKAPE病原体中的抗菌药物耐药性挑战
Microorganisms. 2021 Apr 29;9(5):954. doi: 10.3390/microorganisms9050954.
本文引用的文献
1
Mechanisms of resistance among respiratory tract pathogens.呼吸道病原体的耐药机制。
Clin Lab Med. 2004 Jun;24(2):419-53. doi: 10.1016/j.cll.2004.03.011.
2
Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA: data from PROTEKT US 2000-01.美国社区获得性呼吸道病原体的抗菌药物敏感性：来自2000 - 2001年美国PROTEKT的数据。
J Infect. 2004 Jan;48(1):56-65. doi: 10.1016/s0163-4453(03)00123-3.
3
Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program.流感嗜血杆菌和卡他莫拉菌对口服抗菌药物的敏感性趋势：哨兵抗菌监测计划的五年报告
Diagn Microbiol Infect Dis. 2003 Sep;47(1):373-6. doi: 10.1016/s0732-8893(03)00089-0.
4
The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.1998 - 2000年亚历山大项目：社区获得性呼吸道感染分离病原体对常用抗菌药物的敏感性
J Antimicrob Chemother. 2003 Aug;52(2):229-46. doi: 10.1093/jac/dkg321. Epub 2003 Jul 15.
5
Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program.对氟喹诺酮类药物敏感性降低的流感嗜血杆菌分离株的五年分析：哨兵抗菌监测计划的流行率结果
Diagn Microbiol Infect Dis. 2003 May;46(1):55-61. doi: 10.1016/s0732-8893(03)00016-6.
6
Antimicrobial susceptibility of community-acquired respiratory tract pathogens in North America in 1999-2000: findings of the PROTEKT surveillance study.1999 - 2000年北美社区获得性呼吸道病原体的抗菌药物敏感性：PROTEKT监测研究结果
Diagn Microbiol Infect Dis. 2003 Apr;45(4):251-9. doi: 10.1016/s0732-8893(02)00522-9.
7
Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US.
Int J Antimicrob Agents. 2002 Aug;20(2):76-85. doi: 10.1016/s0924-8579(02)00124-3.
8
The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.PROTEKT监测研究：社区获得性呼吸道感染中流感嗜血杆菌和卡他莫拉菌的抗菌药物敏感性
J Antimicrob Chemother. 2002 Sep;50 Suppl S1:49-59. doi: 10.1093/jac/dkf810.
9
Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain.2000 - 2001年美国对流感嗜血杆菌的抗菌监测导致检测到一种β-内酰胺酶阴性且耐氨苄西林菌株的克隆传播。
J Clin Microbiol. 2002 Mar;40(3):1063-6. doi: 10.1128/JCM.40.3.1063-1066.2002.
10
Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative.
Int J Antimicrob Agents. 2002 Feb;19(2):119-23. doi: 10.1016/s0924-8579(01)00480-0.
Zotero 插件